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serum anti-gastric parietal cell antibody (GPCA) positivity. This study assessed whether serum
GPCA or RAS itself was a significant factor causing hematinic deficiencies and anemia statuses
in GPCA-positive RAS (GPCAþ/RAS) and all autoantibodies-negative RAS (Abs/RAS) patients.
Methods: The mean corpuscular volume (MCV) and mean blood hemoglobin (Hb), iron, vitamin
B12, and folic acid levels were measured and compared between any two of three groups of 31
GPCAþ/RAS patients, 240 Abs/RAS patients, and 342 healthy control subjects.
Results: GPCAþ/RAS patients had significantly lower mean Hb and serum iron level (for women
only) as well as significantly greater frequencies of Hb, iron, and vitamin B12 deficiencies than
healthy control subjects. Moreover, GPCAþ/RAS patients had a significantly higher MCV and a
significantly greater frequency of vitamin B12 deficiency than Abs/RAS patients. Further-
more, Abs/RAS patients did have significantly lower mean Hb, MCV, iron, and folic acid levels
and significantly greater frequencies of Hb, iron, vitamin B12, and folic acid deficiencies thanave no conflicts of interest relevant to this article.
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100 H.-P. Lin et al.healthy control subjects. Of 31 GPCAþ/RAS patients, 3 (9.7%) had PA, 6 (19.4%) had vitamin
B12 deficiency, and 3 (9.7%) had macrocytosis. Moreover, normocytic anemia (54.0%) and iron
deficiency anemia (26.4%) are the two more common types of anemia in our RAS patients.
Conclusions: We conclude that serum GPCA plays a significant role in causing vitamin B12 defi-
ciency and high MCV in GPCAþ/RAS patients. RAS itself does play a significant role in causing
anemia and hematinic deficiencies in both GPCAþ/RAS and Abs/RAS patients.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Recurrent aphthous stomatitis (RAS) is a common oral
mucosal disease characterized by recurrent and painful
ulcerations on the nonkeratinized oral mucosae such as
labial, buccal, alveolar, and ventral tongue mucosae. In
Taiwan, the prevalence of RAS is 10.5% in the general
population.1
Although several etiological factors have been proposed,
the exact causes of RAS are still not very clear.2 Previous
studies of tissue infiltrated mononuclear cells in RAS spec-
imens favor the role of cell-mediated cytotoxicity in the
immunopathogenesis of RAS.3 In addition to immune dys-
regulation, multiple nutritional deficiencies including de-
ficiencies of vitamins B1, B2, B6, and B12, folate, iron, and
ferritin are reported to be the possible etiologies of RAS.3
Our previous studies showed that 57 (20.9%), 55 (20.1%),
13 (4.8%) and 7 (2.6%) of 273 RAS patients have deficiencies
of hemoglobin (Hb), iron, vitamin B12, and folic acid,
respectively.3 We also demonstrated that 13.0%, 19.4%, and
19.7% of 355 RAS patients had the presence of anti-gastric
parietal cell (GPCA), anti-thyroglobulin (TGA), and anti-
thyroid microsomal autoantibodies (TMA) in their sera,
respectively.4 It is well known that GPCA can induce
destruction of gastric parietal cells, resulting in failure of
intrinsic factor production5,6 and vitamin B12 deficiency
that finally leads to the status of pernicious anemia (PA).7,8
Vitamin B12 deficiency may also be due to insufficient
intake of vitamin B12-containing foods, vitamin B12
malabsorption, and transcobalamin II deficiency.8 Because
multiple factors are involved in Hb deficiency (anemia) in
RAS patients, it is interesting to know what factors are most
important for the development of anemia or hematinic
deficiencies in GPCA-positive RAS (GPCAþ/RAS) patients
and all autoantibodies-negative RAS (Abs/RAS) patients.
In our oral mucosal disease clinic, patients with atrophic
glossitis (AG), burning mouth syndrome (BMS), oral lichen
planus (OLP), RAS, oral submucous fibrosis (OSF), and other
oral mucosal diseases are frequently encountered.3,4,9e28
For AG, BMS, OLP, RAS and OSF patients, complete blood
count, serum iron, vitamin B12, folic acid, homocysteine,
serum anti-nuclear autoantibody (ANA), anti-smooth mus-
cle autoantibody (SMA), anti-mitochondrial autoantibody
(AMA), GPCA, TGA, and TMA levels were frequently exam-
ined to assess whether these patients have anemia, he-
matinic deficiencies, and serum ANA, SMA, AMA, GPCA,
TGA, or TMA positivity.3,4,9e25 To assess the roles of GPCA
positivity and the disease of RAS itself in the developmentof anemia and hematinic deficiencies in GPCAþ/RAS and
Abs/RAS patients, 31 GPCAþ/RAS patients without ANA,
SMA, AMA, TGA and TMA positivities and 240 Ab-/RAS pa-
tients were collected. Their complete blood counts as well
as serum iron, vitamin B12, folic acid, and homocysteine
levels were examined and compared with the correspond-
ing data of 342 healthy control subjects without ANA, SMA,
AMA, GPCA, TGA and TMA positivities. The purposes of this
study were to evaluate the hematinic deficiencies and
anemia statuses in these 31 GPCAþ/RAS patients and 240
Abs/RAS patients and to clarify the roles of the serum
GPCA and/or the disease of RAS itself in the final devel-
opment of anemia and hematinic deficiencies in our
GPCAþ/RAS and Abs/RAS patients.Materials and methods
Subjects
In this study, 31 (10 men and 21 women, age range
24e90 years, mean age 63.3  12.9 years) GPCAþ/RAS
patients and 240 (78 men and 162 women, age range
18e90 years, mean age 50.9  16.3 years) Abs/RAS pa-
tients were collected from the oral mucosal disease clinic
of National Taiwan University Hospital (NTUH). For com-
parisons, 342 healthy control subjects (104 men and 238
women, age range 20e89 years, mean age
52.7  14.7 years) were also collected and included in this
study. All RAS patients and control subjects were seen
consecutively, diagnosed, and treated in the Department of
Dentistry, NTUH from July 2007 to July 2016. Patients were
diagnosed as having RAS when they had at least one episode
of oral ulcerations on movable oral mucosa per month since
childhood.3 RAS patients with betel quid chewing habit or
autoimmune diseases (such as systemic lupus erythemato-
sus, rheumatoid arthritis, Sjogren’s syndrome, pemphigus
vulgaris, and cicatricial pemphigoid) were excluded.
Moreover, patients with traumatic ulcers or with aphthous-
like ulcers associated with systemic disorders including
Behcet’s syndrome, celiac disease, gluten-sensitive enter-
opathy, inflammatory bowel diseases, human immunodefi-
ciency virus infection, and cyclic neutropenia were also
excluded.29 In addition, RAS patients with serum creatinine
concentrations indicative of renal dysfunction (i.e., men,
>131 mmol/L; women, >115 mmol/L), and who reported a
history of stroke, heavy alcohol use, or diseases of the liver,
kidney, or coronary arteries were also excluded.30 Healthy
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malocclusion, or missing of teeth but did not have any oral
mucosal or systemic diseases. None of the RAS patients had
taken any prescription medication for RAS at least 3 months
before entering the study.
The blood samples were drawn from all included RAS
patients and healthy control subjects for measurement of
complete blood count, serum iron, vitamin B12, folic acid,
and homocysteine concentrations as well as serum ANA,
SMA, AMA, GPCA, TGA, and TMA levels. All RAS patients and
healthy control subjects signed the informed consents
before entering the study. This study was reviewed and
approved by the Institutional Review Board at the NTUH.
Determination of complete blood count and serum
iron, vitamin B12, folic acid and homocysteine
concentrations
The complete blood count and serum iron, vitamin B12,
folic acid, and homocysteine concentrations were deter-
mined by the routine tests performed in the Department of
Laboratory Medicine of NTUH as described pre-
viously.3,10e25 This study defined the Hb and hematinic
deficiencies according to the World Health Organization
(WHO) criteria. Thus, men with Hb < 13 g/dL and women
with Hb < 12 g/dL were defined as having Hb deficiency or
anemia.20,31 Patients with serum iron level <60 mg/dL,32
vitamin B12 level <200 pg/mL30 or folic acid level <4 ng/
mL33 were defined as having iron, vitamin B12 or folic acid
deficiency, respectively. Moreover, patients with the serum
homocysteine level >12.3 mM (which was the mean serum
homocysteine level of healthy control subjects plus two
standard deviations) were defined as having abnormally
high homocysteine level.
Determination of serum ANA, SMA, AMA, GPCA,
TGA, and TMA levels
The methods of determination of serum ANA, SMA, AMA,
GPCA, TGA, and TMA levels in our RAS patients and healthy
control subjects have been described in our previous
studies.4,9e14,17
Statistical analysis
Comparisons of the mean MCV and mean blood levels of Hb,
iron, vitamin B12, folic acid and homocysteine between
GPCAþ/RAS patients or Abs/RAS patients and healthy
control subjects and between GPCAþ/RAS patients and
Abs/RAS patients were performed by Student’s t-test.
The differences in frequency of Hb, iron, vitamin B12 or
folic acid deficiency, or frequency of abnormally high blood
homocysteine level between GPCAþ/RAS patients or Abs/
RAS patients and healthy control subjects and between
GPCAþ/RAS patients and Abs/RAS patients were
compared by chi-square test. Comparisons of mean MCV
and mean blood concentrations of Hb, iron, vitamin B12,
folic acid and homocysteine between any two of the three
groups of patients with macrocytic, normocytic or micro-
cytic RBCs were performed by Student’s t-test. The resultwas considered to be significant if the P-value was less than
0.05.Results
The mean MCV and mean blood concentrations of Hb, iron,
vitamin B12, folic acid, and homocysteine in 31 GPCAþ/RAS
patients, 240 Abs/RAS patients, and 342 healthy control
subjects are shown in Table 1. Because men usually had
higher blood levels of Hb and iron than women, these two
mean levels were calculated separately for men and
women. We found significantly lower mean Hb (for men and
women, both P-values < 0.001) and serum iron level (for
women only; PZ 0.014) as well as significantly higher mean
blood homocysteine level (P < 0.001) in GPCAþ/RAS pa-
tients than in healthy control subjects (Table 1). Moreover,
we found a significantly higher mean MCV (P Z 0.002) and
folic acid level (P Z 0.039) as well as a significantly higher
mean blood homocysteine level (PZ 0.012) in GPCAþ/RAS
patients than in Abs/RAS patients. Furthermore, Abs/
RAS patients did have significantly lower mean Hb (for men
and women, both P-values < 0.001), MCV (P < 0.001),
serum iron (for men and women, both P-values < 0.001),
vitamin B12 (P Z 0.072, marginal significance), and folic
acid (PZ 0.005) levels than healthy control subjects (Table
1).
We also found significantly greater frequencies of Hb,
serum iron and vitamin B12 deficiencies and of high blood
homocysteine level in GPCAþ/RAS patients than in healthy
control subjects (all P-values < 0.001) (Table 2). There
were also significantly greater frequencies of vitamin B12
deficiency (P Z 0.037) and of high serum homocysteine
level (P Z 0.077, marginal significance) in GPCAþ/RAS
patients than in Abs/RAS patients. Moreover, we also
demonstrated significantly greater frequencies of Hb,
serum iron, vitamin B12, and folic acid deficiencies and of
high blood homocysteine level (all P-values < 0.001) in
Abs/RAS patients than in healthy control subjects (Table
2).
In this study, 10 (32.3%) of 31 GPCAþ/RAS patients and
77 (32.1%) of 240 Abs/RAS patients were diagnosed as
having anemia according to the WHO criteria (Table 3).31
The different anemia types of 10 anemic GPCAþ/RAS pa-
tients and of 77 anemic Abs/RAS patients are shown in
detail in Table 3. In this study, PA was diagnosed as having
MCV  100 fl, vitamin B12 < 200 pg/mL, and serum GPCA
positivity,17e19 iron deficiency anemia as having MCV < 80 fl
and iron <60 mg/dL31,32; and thalassemia trait as having
MCV < 74 fl, RBC count >5.0  1012/L, and Mentzer index
(MCV/RBC) < 13.23 By these definitions, of 10 anemic
GPCAþ/RAS patients, 3 had PA, 4 had normocytic anemia, 2
had iron deficiency anemia, and one had microcytic anemia
but did not have iron deficiency and thalassemia trait.
Moreover, of 77 anemic Abs/RAS patients, 6 had macro-
cytic anemia, 43 had normocytic anemia, 21 had iron
deficiency anemia, 5 had thalassemia trait, and two had
microcytic anemia but did not have iron deficiency.
When 31 GPCAþ/RAS patients were further divided into
three groups: group 1 (3 patients with MCV  100 fl), group
2 (25 patients with MCV between 80 fl and 99.9 fl), and
group 3 (3 patients with MCV < 80 fl), we found that group 1
Table 1 Comparisons of the mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin
B12, folic acid and homocysteine between any two of the three groups of 31 anti-gastric parietal cell antibody (GPCA)-positive
recurrent aphthous stomatitis (RAS) patients (GPCAþ/RAS patients), 240 all autoantibodies-negative RAS patients (Abs/RAS
patients), and 342 healthy control subjects.
Group Hb (g/dL) MCV (fl) Iron (mg/dL) Vitamin B12
(pg/mL)
Folic acid
(ng/mL)
Homocysteine
(mM)Men Women Men Women
GPCAþ/RAS patients
(n Z 31)
13.9  1.9
(n Z 10)
12.8  1.0
(n Z 21)
92.2  9.5 102.7  39.8
(n Z 10)
82.9  30.8
(n Z 21)
613.7  314.8 15.3  6.1 12.8  12.7
P-valuea <0.001 <0.001 0.074 0.858 0.014 0.174 0.280 <0.001
P-valueb 0.730 0.343 0.002 0.252 0.854 0.637 0.039 0.012
Abs/RAS patients
(n Z 240)
14.1  1.7
(n Z 78)
12.5  1.4
(n Z 162)
87.2  8.1 88.8  35.4
(n Z 78)
81.4  35.6
(n Z 162)
638.4  268.6 12.6  6.9 8.7  7.8
P-valuea <0.001 <0.001 <0.001 <0.001 <0.001 0.072 0.005 0.649
Healthy control
subjects
(n Z 342)
15.2  0.7
(n Z 104)
13.6  0.7
(n Z 238)
90.7  3.7 104.4  27.4
(n Z 104)
98.8  28.1
(n Z 238)
676.5  238.6 14.1  5.9 8.5  1.9
a Comparisons of parameters between 31 GPCAþ/RAS patients or 240 Abs/RAS patients and 342 healthy control subjects.
b Comparisons of parameters between 31 GPCAþ/RAS patients and 240 Abs/RAS patients.
Table 2 Comparisons of frequencies of hemoglobin (Hb), iron, vitamin B12, and folic acid deficiencies and frequency of
abnormally high blood homocysteine level between any two of the three groups of 31 anti-gastric parietal cell antibody (GPCA)-
positive recurrent aphthous stomatitis (RAS) patients (GPCAþ/RAS patients), 240 all autoantibodies-negative RAS patients
(Abs/RAS patients), and 342 healthy control subjects.
Hb deficiency
(Men < 13 g/dL,
Women < 12 g/dL)
Iron deficiency
(<60 mg/dL)
Vitamin B12
deficiency
(<200 pg/mL)
Folic acid
deficiency
(<4 ng/mL)
High homocysteine
level (>12.3 mM)
GPCAþ/RAS
patients (n Z 31)
10 (32.3%) 6 (19.4%) 6 (19.4%) 0 (0.0%) 7 (22.6%)
P-valuea <0.001 <0.001 <0.001 ND <0.001
P-valueb 0.853 0.426 0.037 0.418 0.077
Abs/RAS
patients (n Z 240)
77 (32.1%) 67 (27.9) 16 (6.7%) 12 (5%) 24 (10%)
P-valuea <0.001 <0.001 <0.001 <0.001 <0.001
Healthy control
subjects (n Z 342)
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (0.9%)
ND Z not done.
a Comparisons of parameters between 31 GPCAþ/RAS patients or 240 Abs/RAS patients and 342 healthy control subjects.
b Comparisons of parameters between 31 GPCAþ/RAS patients and 240 Abs/RAS patients.
102 H.-P. Lin et al.patients had significantly higher MCV (P < 0.001), lower
mean Hb (for men only, P Z 0.007) and serum vitamin B12
(P Z 0.002) levels, as well as higher mean serum folic acid
(PZ 0.006) and homocysteine (P < 0.001) levels than group
2 patients (Table 4). Moreover, group 3 patients had
significantly lower mean Hb level (for women only,
PZ 0.004), lower MCV (P < 0.001), lower mean serum iron
level (for women only, P Z 0.027), and higher mean blood
homocysteine level (P Z 0.002) than group 2 patients
(Table 4). In addition, group 1 patients had significantly
higher MCV (P < 0.001) than group 3 patients (Table 4).
We also divided 240 Abs/RAS patients into three
groups: group 1 (6 patients with MCV  100 fl), group 2 (200
patients with MCV between 80 fl and 99.9 fl), and group 3
(34 patients with MCV < 80 fl). We found that group 1 pa-
tients had significantly higher MCV (P < 0.001), lower mean
Hb (for men, P < 0.001; for women, P Z 0.049) and serum
vitamin B12 (P < 0.001) levels, and higher mean serum folicacid (P Z 0.050, marginal significance) and homocysteine
(P < 0.001) levels than group 2 patients (Table 5). More-
over, group 3 patients had significantly lower mean Hb level
(for men and women, both P-values < 0.001), lower MCV
(P < 0.001), lower mean serum iron level (for men,
P Z 0.006, for women, P < 0.001), and lower mean serum
folic acid level (PZ 0.015) than group 2 patients (Table 5).
In addition, group 1 patients had significantly higher MCV
(P < 0.001), higher mean serum iron level (for women only,
P Z 0.033), lower mean serum vitamin B12 (P Z 0.028),
and higher mean serum folic acid (P Z 0.004) and homo-
cysteine (P < 0.001) levels than group 3 patients (Table 5).Discussion
This study found that GPCAþ/RAS patients had significantly
lower mean Hb and serum iron level (for women only), and
Table 3 Anemia types of 10 of 31 anti-gastric parietal cell antibody (GPCA)-positive recurrent aphthous stomatitis (RAS)
patients (GPCAþ/RAS patients) and of 77 of 240 all autoantibodies-negative RAS patients (Abs/RAS patients).
Anemia type Patient number (%)
Patient
number (%)
MCV Vitamin B12
deficiency
(<200 pg/mL)
Iron deficiency
(<60 mg/dL)
Folic acid
deficiency
(<4 ng/mL)
GPCAD/RAS patients (n [ 31)
Pernicious anemia 3 (30.0) 100 fl 3 (100.0) 0 (0.0) 0 (0.0)
Normocytic anemia 4 (40.0) 80e99.9 fl 0 (0.0) 2 (50.0) 0 (0.0)
Iron deficiency anemia 2 (20.0) <80 fl 1 (50.0) 2 (100.0) 0 (0.0)
Microcytic anemia 1 (10.0) <80 fl 1 (100.0) 0 (0.0) 0 (0.0)
Total 10 (100.0) 5 (50.0) 4 (40.0) 0 (0.0)
AbsL/RAS patients (n [ 240)
Macrocytic anemia 6 (7.8) 100 fl 5 (83.3) 1 (16.7) 0 (0.0)
Normocytic anemia 43 (55.8) 80e99.9 fl 3 (7.0) 23 (53.5) 3 (7.0)
Iron deficiency anemia 21 (27.3) <80 fl 2 (9.5) 21 (100.0) 3 (14.3)
Thalassemia trait 5 (6.5) <74 fl 0 (0.0) 0 (0.0) 0 (0.0)
Microcytic anemia 2 (2.6) <80 fl 0 (0.0) 0 (0.0) 1 (50.0)
Total 77 (100.0) 10 (13.0) 45 (58.4) 7 (9.1)
Table 4 The mean corpuscular volume (MCV), mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic acid,
and homocysteine in 31 anti-gastric parietal cell antibody (GPCA)-positive recurrent aphthous stomatitis (RAS) patients
(GPCAþ/RAS patients), including 3 with MCV  100 fl (group 1), 25 with MCV between 80 fl and 99.9 fl (group 2), and 3 with
MCV < 80 fl (group 3).
GPCAþ/RAS patients (n Z 31)
Group 1
MCV  100 fl
(n Z 3)
P-valuea
(Group 1 vs. 2)
Group 2
MCV 80-99.9 fl
(n Z 25)
P-valuea
(Group 2 vs. 3)
Group 3
MCV < 80 fl
(n Z 3)
P-valuea
(Group 1 vs. 3)
Mean  SD Mean  SD Mean  SD
Hb (g/dL)
Men 11.3  0.0
(n Z 2)
0.007 14.9  1.3
(n Z 7)
ND 12.0 (n Z 1) ND
Women 11.3 (n Z 1) ND 13.1  0.9
(n Z 18)
0.004 10.8  1.5
(n Z 2)
ND
MCV (fl) 114.5  5.3 <0.001 91.5  3.4 <0.001 75.6  2.8 <0.001
Iron (mg/dL)
Men 77.5  3.5
(n Z 2)
0.430 104.9  44.1
(n Z 7)
ND 138.0 (n Z 1) ND
Women 91 (n Z 1) ND 87.5  28.7
(n Z 18)
0.027 37.0  15.6
(n Z 2)
ND
Vitamin B12
(pg/mL)
150.0  0.0 0.002 689.6  261.1 0.171 445.0  481 0.348
Folic acid
(ng/mL)
24.0  0.0 0.006 14.0  5.7 0.450 16.7  6.4 0.119
Homocysteine
(mM)
32.6  24.2 <0.001 8.9  3.1 0.002 25.3  26.7 0.743
ND Z not done.
a Comparisons of MCV, mean blood concentrations of Hb, iron, vitamin B12, folic acid and homocysteine between groups 1 and 2,
between groups 2 and 3, and between groups 1 and 3 by Student’s t-test.
Anemia in recurrent aphthous stomatitis patients 103significantly higher mean serum homocysteine level than
healthy control subjects. Moreover, GPCAþ/RAS patients
had significantly greater frequencies of Hb, serum iron, and
serum vitamin B12 deficiencies and of high serum homo-
cysteine level than healthy control subjects. These twofindings suggest that the anemia status and hematinic de-
ficiencies in GPCAþ/RAS patients can be attributed to
either serum GPCA positivity or the disease of RAS itself or
both. To elucidate these equivocal probabilities, we
compared the blood data between 31 GPCAþ/RAS patients
Table 5 The mean corpuscular volume (MCV), mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic acid,
and homocysteine in 240 all autoantibodies-negative recurrent aphthous stomatitis (RAS) patients (Abs/RAS patients)
including 6 with MCV  100 fl (group 1), 200 with MCV between 80 fl and 99.9 fl (group 2), and 34 with MCV < 80 fl (group 3).
Abs/RAS patients (n Z 240)
Group 1
MCV  100 fl
(n Z 6)
P-valuea
(Group 1 vs. 2)
Group 2
MCV 80-99.9 fl
(n Z 200)
P-valuea
(Group 2 vs. 3)
Group 3
MCV < 80 fl
(n Z 34)
P-valuea
(Group 1 vs. 3)
Mean  SD Mean  SD Mean  SD
Hb (g/dL)
Men 11.8  0.9
(n Z 4)
<0.001 14.5  1.4
(n Z 66)
<0.001 12.3  1.6
(n Z 8)
0.580
Women 11.1  1.2
(n Z 2)
0.049 12.8  1.2
(n Z 134)
<0.001 10.9  1.1
(n Z 26)
0.807
MCV (fl) 107.4  4.9 <0.001 89.2  3.9 <0.001 71.9  6.1 <0.001
Iron (mg/dL)
Men 110.0  78.5
(n Z 4)
0.296 91.2  31.2
(n Z 66)
0.006 58.5  28.0
(n Z 8)
0.117
Women 126.0  72.1
(n Z 2)
0.077 86.2  30.8
(n Z 134)
<0.001 53.5  42.5
(n Z 26)
0.033
Vitamin B12 (pg/mL) 294.8  300.0 <0.001 658.3  258.4 0.118 582.2  281.0 0.028
Folic acid (ng/mL) 18.5  5.1 0.050 12.9  6.9 0.015 9.8  6.5 0.004
Homocysteine (mM) 33.8  39.7 <0.001 8.0  3.4 0.429 8.5  3.4 <0.001
a Comparisons of MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid and homocysteine between groups 1 and 2,
between groups 2 and 3, and between groups 1 and 3 by Student’s t-test.
104 H.-P. Lin et al.and 240 Abs/RAS patients. We found GPCAþ/RAS patients
did have significantly higher MCV and higher serum homo-
cysteine level as well as significantly greater frequencies of
vitamin B12 deficiency and of high serum homocysteine
level than Abs/RAS patients. These findings indicate that
the serum GPCA plays an important role in causing vitamin
B12 deficiency, higher MCV, and higher homocysteine level
in GPCAþ/RAS patients. Although the serum GPCA has some
contributions to cause the anemia, it does not play a sig-
nificant role in causing anemia in GPCAþ/RAS patients.
Furthermore, this study also found that Abs/RAS patients
did have significantly lower mean Hb, MCV, serum iron, and
folic acid levels as well as significantly greater frequencies
of Hb, iron, vitamin B12, and folic acid deficiencies and of
high blood homocysteine level than healthy control sub-
jects. These findings indicate that the disease of RAS itself
does play a significant role in causing anemia, hematinic
deficiencies, and high blood homocysteine level in Abs/
RAS patients.
The serum GPCA can induce destruction of gastric pari-
etal cells, resulting in failure of intrinsic factor produc-
tion5,6 and vitamin B12 deficiency that finally leads to
macrocytosis and the status of PA.7,8 Our previous studies
demonstrated that vitamin B12 and folic acid deficiencies
can lead to high serum homocysteine level in oral mucosal
disease patients.3,10-18 Supplementation of multiple B vi-
tamins especially vitamin B12 and folic acid can reduce the
serum homocysteine levels in patients with AG or BMS.24,34
Thus, the higher frequency of vitamin B12 deficiency,
higher MCV, and higher homocysteine level in GPCAþ/RAS
patients than in healthy control patients are predominantly
due to the presence of GPCA in GPCAþ/RAS patients’ sera.
Here, we explained why anemia and hematinic de-
ficiencies may be etiological factors for the disease of RAS.Our previous study showed Hb, serum iron, vitamin B12,
and folic acid deficiencies in 57 (20.9%), 55 (20.1%), 13
(4.8%), and 7 (2.6%) of 273 RAS patients, respectively.3 In
addition, a high homocysteine level was found in 21 (7.7%)
of 273 RAS patients.3 Our previous RAS study also described
deficiencies of vitamins B1, B2, B6 and B12, folate, iron,
ferritin and Hb in a portion of RAS patients.3 Iron deficiency
causes microcytic anemia32 and deficiencies of vitamin B12
and folic acid lead to macrocytic anemia.19,30 RAS patients
with anemia and lower Hb levels have reduced capacity of
the blood to carry oxygen to oral mucosa, finally resulting in
atrophy of oral mucosa. In addition, iron is essential to the
normal functioning of oral epithelial cells35 and both
vitamin B12 and folic acid play important roles in DNA
synthesis and cell division.3,30 Oral epithelial cells have a
high turnover rate. Therefore, deficiencies of iron, vitamin
B12, and folic acid may result in oral epithelial atrophy.
Atrophic oral epithelium in hematinic-deficient patients
may explain why some patients with deficiencies of hema-
tinics are prone to have RAS. Furthermore, high blood ho-
mocysteine level may result in an elevated frequency of
thrombosis in the feeding arterioles that supply the oral
epithelial cells.36e40 This in turn leads to a breakdown of
oral epithelium and finally produces an oral ulceration.
Moreover, replacement therapy with hematinics for RAS
patients with deficiencies of corresponding hematinics can
result in a significant clinical improvement or at least a
reduction in frequency and severity of their oral aphthous
ulcers.41e44 Taken these together, anemia, hematinic de-
ficiencies, and high blood homocysteine levels can decrease
oral epithelial barrier and thus increase the frequency of
RAS occurrence. Moreover, Hb and hematinic deficiencies
and high blood homocysteine level may be the important
etiological factors for RAS.
Anemia in recurrent aphthous stomatitis patients 105We further explain why RAS itself may be an important
factor causing anemia and hematinic deficiencies in RAS
patients. The results of a previous diet history question-
naire study indicate a significantly lower daily intake of
vitamin B12 and folate in minor-typed RAS patients than in
control subjects.45 These results suggest that even the
small oral ulcerations may impede the food intake by
minor-typed RAS patients. By definition, the major-typed
RAS patients often have severer and larger recurrent oral
ulcerations than minor-typed RAS patients.3 These severer
ulcerative lesions may cause burning sensation and pain of
the lesional oral mucosae when the patients eat salty and
spicy food stuffs. The eating difficulty may result in
reduced food intake that in turn leads to anemia and he-
matinic deficiencies in a certain percentage of our RAS
patients.
In this study, 10 (32.3%) of the 31 GPCAþ/RAS patients
and 77 (32.1%) of 240 Ab-/RAS patients had anemia.20,31 Six
types of anemia including pernicious, macrocytic, normo-
cytic, iron deficiency, and microcytic anemia and thalas-
semia trait were detected in RAS patients. We also found
that 3 of 3 PA patients and 5 of 6 macrocytic anemia pa-
tients (one patient had concomitant iron deficiency) had
vitamin B12 but not folic acid deficiency, suggesting that
these two types of anemia are predominantly due to
vitamin B12 deficiency. Of 47 normocytic anemia patients,
25 (53.2%) had iron deficiency, 3 (6.4%) had vitamin B12
deficiency, and 3 (6.4%) had folic acid deficiency, indicating
that normocytic anemia in our RAS patients are predomi-
nantly due to iron deficiency and secondarily due to vitamin
B12 and folic acid deficiencies. In our 23 iron deficiency
anemia patients, 3 (13.0%) had concomitant vitamin B12
deficiency and another 3 (13.0%) had folic acid deficiency,
suggesting that except for iron deficiency, both vitamin B12
and folic acid deficiencies may have a minor contribution to
cause anemia in iron deficiency anemia patients. None of
our 5 thalassemia trait patients had vitamin B12, iron or
folic acid deficiency. The three microcytic anemia patients
did not have iron deficiency, but one of them had vitamin
B12 deficiency and another one had folic acid deficiency. Of
31 GPCAþ/RAS patients, 3 (9.7%) had PA, 6 (19.4%) had
vitamin B12 deficiency, and 3 (9.7%) had macrocytosis.
Furthermore, 3 (50%) of 6 vitamin B12-deficient and 3
(100%) of 3 macrocytosis GPCAþ/RAS patients had PA. Our
findings indicate that only approximately 10e20% GPCAþ/
RAS patients had PA, vitamin B12 deficiency, or macrocy-
tosis. Moreover, normocytic anemia (54.0%) and iron defi-
ciency anemia (26.4%) are the two more common types of
anemia in our RAS patients.
Of the 31 GPCAþ/RAS patients, 3 (9.7%, group 1 pa-
tients) produced macrocytic RBCs, 25 (80.6%, group 2 pa-
tients) normocytic RBCs, and 3 (9.7%, group 3 patients)
microcytic RBCs. Compared to group 2 patients, both
groups 1 and 3 patients had relatively severe anemia, group
3 patients tended to have relatively low serum iron level,
group 1 patients usually had low serum vitamin B12 level
and significantly high blood homocysteine level, and group
3 patients usually had no vitamin B12 and folic acid de-
ficiencies. A similar tendency was also observed in 240
Abs/RAS patients including 6 macrocytosis (group 1), 200
normocytosis (group 2), and 34 microcytosis (group 3)
Abs/RAS patients.GPCAþ/RAS patients may tend to have intrinsic factor
deficiency that finally results in vitamin B12 deficiency.17e19
Therefore, it is interesting to know why 25 (80.6%) of our 31
GPCAþ/RAS patients do not have vitamin B12 deficiency. It
has been reported that supplementation with oral vitamin
B12 is a safe and effective treatment for the correction of
vitamin B12 deficiency state. Even when intrinsic factor is
not present to aid the absorption of vitamin B12 or in other
diseases that affect the usual absorption sites in the ter-
minal ileum, oral supplement therapy with vitamin B12
remains effective.8,18 Therefore, although patients have
GPCA in their sera, enough dietary supply of vitamin B12
may prevent the occurrence of vitamin B12 deficiency in
these 25 GPCAþ/RAS patients. In addition, for those GPCA-
positive patients it may need an enough long period of time
to develop the autoimmune gastritis and finally resulting in
complete failure of intrinsic factor production.7,46 There-
fore, for patients with lower serum titer of GPCA or those
with medium or higher serum titer of GPCA of a shorter
duration, their residual gastric parietal cells may still have
some ability to produce intrinsic factors that help to absorb
vitamin B12 from the small intestine.12,17,18
We conclude that the serum GPCA plays a significant role
in causing vitamin B12 deficiency, higher MCV, and higher
homocysteine level in GPCAþ/RAS patients. Although the
serum GPCA has some contributions to cause the anemia, it
does not play a significant role in causing anemia in GPCAþ/
RAS patients. The disease of RAS itself does play a signifi-
cant role in causing anemia and hematinic deficiencies in
both GPCAþ/RAS and Abs/RAS patients.
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